Richard D. Truesdell, Jr.
Lawyers
Filters
United Technologies $6.5 billion unsecured bridge facility
Davis Polk advised the joint lead arrangers and joint bookrunners in connection with a $6.5 billion 364-day senior unsecured bridge loan facility for United Technology Corporation to…
Davis Polk Advises Tyson Foods on Its $900 Million Senior Notes Offerings
Davis Polk advised Tyson Foods, Inc. in connection with its SEC-registered offerings of $900 million aggregate principal amount of senior notes in two series, consisting of $400 million…
Celgene $500 Million Notes Offering
Davis Polk advised the sole book-running manager on an SEC-registered offering by Celgene Corporation of $500 million aggregate principal amount of 2.250% senior notes due 2021. …
Spark Therapeutics Follow-On Offering
Davis Polk advised the representative of the underwriters in connection with the $402.5 million public offering of 5,296,053 shares of common stock of Spark Therapeutics, Inc. The…
Davis Polk Advises Tamar Petroleum on Its International Initial Public Offering
Davis Polk advised Delek Drilling LP, as the selling shareholder, and Tamar Petroleum Limited, as the issuer, on Tamar Petroleum’s international offering of 2,660,000 of its ordinary shares…
Davis Polk Advises Calyxt, Inc. on Its Initial Public Offering
Davis Polk advised Calyxt, Inc. in connection with its initial public offering of 8,050,000 shares of its common stock, including 1,050,000 shares of common stock sold pursuant to the full…
Davis Polk Advises IHS Markit Ltd. on Its $300 Million Senior Notes Reopening
Davis Polk advised IHS Markit Ltd. in connection with its Rule 144A/Regulation S offering of an additional $300 million aggregate principal amount of its 4.75% senior notes due 2025. …
Mersana Therapeutics, Inc. Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $75 million initial public offering of common stock of Mersana Therapeutics…
Evolent Health, Inc. Common Stock Secondary Offering
Davis Polk advised the representative of the several underwriters in connection with a secondary offering of 4,500,000 shares of Class A common stock of Evolent Health, Inc. by certain of…
Davis Polk Advises Pattern Energy’s Conflicts Committee on Strategic Initiatives for Expansion of Growth and Capital Opportunities
Davis Polk is advising the Conflicts Committee of the board of directors of Pattern Energy Group Inc. in connection with a series of strategic initiatives to increase Pattern Energy’s long…